Interpace Diagnostics, SelectHealth Sign Patient Coverage Agreement for Thyroid Cancer Tests

Interpace Diagnostics announced that it has signed an agreement with SelectHealth/Intermountain Healthcare to offer its thyroid cancer detection assays to SelectHealth's members in Utah and Idaho. 

In addition, Interpace said it will act as an in-network laboratory for these services to SelectHealth's members.

INDUSTRY NEWS TAGS: Molecular Diagnostics

Share This Post:

Search Billing News

Billing News By TAG

Billing News By DATE